Ofev Effective in Elderly Patients, Those With Comorbidities

Ofev Effective in Elderly Patients, Those With Comorbidities

293307

Ofev Effective in Elderly Patients, Those With Comorbidities

Treatment with Ofev (nintedanib) is safe and can preserve lung function in people with idiopathic pulmonary fibrosis (IPF) who are elderly or have several other health conditions, a new study indicates. The study, “Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities,” was published in Respiratory Research and funded by Boehringer Ingelheim, which markets Ofev. Ofev is an approved anti-fibrotic treatment for IPF that can improve patients’ lung…

You must be logged in to read/download the full post.